Results 251 to 260 of about 48,818 (277)

Drugs for Postmenopausal Osteoporosis

The Medical Letter on Drugs and Therapeutics
Pharmacologic treatment is recommended for postmenopausal women who have bone density T-scores (standard deviations from normal mean values in the spine, femoral neck, total hip, or distal radius) of -2.5 or below, T-scores between -1.0 and -2.5 with a history of fragility (low-trauma) fracture of the hip or spine, or T-scores between -1.0 and -2.5 ...
openaire   +2 more sources

Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion

Expert Review of Clinical Pharmacology, 2021
Filippo Migliorini, Giorgia Colarossi, Alice Baroncini   +2 more
exaly  

Pharmacotherapy for Postmenopausal Osteoporosis

JAMA, 2021
openaire   +2 more sources

Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013–2016

Environment International, 2021
Ruxianguli Aimuzi, Min Nian
exaly  

POSTMENOPAUSAL OSTEOPOROSIS

The Lancet, 1979
openaire   +2 more sources

Postmenopausal Osteoporosis

New England Journal of Medicine, 2005
openaire   +2 more sources

Senile and Postmenopausal Osteoporosis

Hormone Research, 2008
M, Peacock, A, Horsman, D H, Marshall, J E, Aaron, R M, Francis, P L, Selby   +5 more
openaire   +2 more sources

The PMPO Syndrome (Postmenopausal Palpable Ovary Syndrome)

Ca-A Cancer Journal for Clinicians, 1972
Hugh R K Barber, Edward A Graber
exaly  

VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis

Endocrine Reviews, 2002
Ann Cranney, Peter Tugwell, Nicole Zytaruk   +2 more
exaly  

IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis

Endocrine Reviews, 2002
Ann Cranney, Peter Tugwell, Nicole Zytaruk   +2 more
exaly